SD Biosensor and SJL Partners completed the acquisition of Meridian Bioscience for $1.53bn.

SD Biosensor, a diagnostic reagents provider, and SJL Partners, a private equity investment manager, completed the acquisition of Meridian Bioscience, a provider of diagnostic testing solutions, for $1.53bn. "This announcement follows an extensive and deliberate review of Meridian's growth and value creation opportunities in the context of the broader macroeconomic and industry environment. In consultation with external financial advisors and following outreach to potential strategic and financial partners, the Board unanimously agreed that this transaction represents the best path forward for Meridian shareholders, providing them with immediate, compelling and certain value, while enabling the Company to benefit from SDB's and SJL's capital support, expertise and experience," John C. McIlwraith, Meridian Chairman.